VIEMED HEALTHCARE, INC. Income (Loss) from Equity Method Investments
VIEMED HEALTHCARE, INC. (VMD) reported Income (Loss) from Equity Method Investments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2026-03-04
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for the quarter ending 2025-12-31 was $0.00.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for the quarter ending 2025-06-30 was $0.00.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for fiscal 2025 was $0.00.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for fiscal 2024 was -$954.00K, a 296.70% decline from fiscal 2023.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for fiscal 2023 was $485.00K, a 48.13% decline from fiscal 2022.
- VIEMED HEALTHCARE, INC. income (loss) from equity method investments for fiscal 2022 was $935.00K, a 24.66% decline from fiscal 2021.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $0.00 10-K · filed 2026-03-04 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-03-04 | $96.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-03-04 | $96.00K derived: sum of 3 quarters · filed 2026-03-04 | -$1.02M derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $96.00K derived: sum of 2 quarters · filed 2026-03-04 | -$1.02M derived: sum of 3 quarters · filed 2026-03-04 | -$954.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $96.00K 10-Q · filed 2025-11-05 | -$1.02M derived: sum of 2 quarters · filed 2025-11-05 | -$954.00K 10-Q · filed 2025-11-05 | -$911.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-06-30 | -$1.12M 10-Q · filed 2025-08-06 | -$1.05M 10-Q · filed 2025-08-06 | -$1.01M derived: sum of 3 quarters · filed 2026-03-04 | -$737.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2024-03-31 | $67.00K 10-Q · filed 2025-05-07 | $110.00K derived: sum of 2 quarters · filed 2026-03-04 | $380.00K derived: sum of 3 quarters · filed 2026-03-04 | $517.00K derived: sum of 4 quarters · filed 2026-03-04 |
| 2023-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $313.00K derived: sum of 2 quarters · filed 2026-03-04 | $450.00K derived: sum of 3 quarters · filed 2026-03-04 | $485.00K 10-K · filed 2026-03-04 |
| 2023-09-30 | $270.00K 10-Q · filed 2024-11-06 | $407.00K derived: sum of 2 quarters · filed 2024-11-06 | $442.00K 10-Q · filed 2024-11-06 | $524.00K derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-06-30 | $137.00K 10-Q · filed 2024-08-07 | $172.00K 10-Q · filed 2024-08-07 | $254.00K derived: sum of 3 quarters · filed 2025-03-10 | $338.00K derived: sum of 4 quarters · filed 2025-03-10 |
| 2023-03-31 | $35.00K 10-Q · filed 2024-05-06 | $117.00K derived: sum of 2 quarters · filed 2025-03-10 | $201.00K derived: sum of 3 quarters · filed 2025-03-10 | $647.00K derived: sum of 4 quarters · filed 2025-03-10 |
| 2022-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $166.00K derived: sum of 2 quarters · filed 2025-03-10 | $612.00K derived: sum of 3 quarters · filed 2025-03-10 | $935.00K 10-K · filed 2025-03-10 |
| 2022-09-30 | $84.00K 10-Q · filed 2023-11-01 | $530.00K derived: sum of 2 quarters · filed 2023-11-01 | $853.00K 10-Q · filed 2023-11-01 | $1.31M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $446.00K 10-Q · filed 2023-08-09 | $769.00K 10-Q · filed 2023-08-09 | $1.23M derived: sum of 3 quarters · filed 2023-08-09 | $1.56M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $323.00K 10-Q · filed 2023-05-08 | $782.00K derived: sum of 2 quarters · filed 2023-05-08 | $1.11M derived: sum of 3 quarters · filed 2023-05-08 | $1.34M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $790.00K derived: sum of 2 quarters · filed 2023-03-02 | $1.02M derived: sum of 3 quarters · filed 2023-03-02 | $1.24M 10-K · filed 2023-03-02 |
| 2021-09-30 | $331.00K 10-Q · filed 2022-11-01 | $562.00K derived: sum of 2 quarters · filed 2022-11-01 | $782.00K 10-Q · filed 2022-11-01 | $837.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $231.00K 10-Q · filed 2022-08-02 | $451.00K 10-Q · filed 2022-08-02 | $506.00K derived: sum of 3 quarters · filed 2022-08-02 | $527.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $220.00K 10-Q · filed 2022-05-03 | $275.00K derived: sum of 2 quarters · filed 2022-05-03 | $296.00K derived: sum of 3 quarters · filed 2022-05-03 | $338.00K derived: sum of 4 quarters · filed 2022-05-03 |
| 2020-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $76.00K derived: sum of 2 quarters · filed 2022-03-07 | $118.00K derived: sum of 3 quarters · filed 2022-03-07 | $91.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-02 | $63.00K derived: sum of 2 quarters · filed 2021-11-02 | $36.00K 10-Q · filed 2021-11-02 | $3.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $42.00K 10-Q · filed 2021-08-03 | $15.00K 10-Q · filed 2021-08-03 | -$18.00K derived: sum of 3 quarters · filed 2021-08-03 | -$44.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | -$27.00K 10-Q · filed 2021-05-03 | -$60.00K derived: sum of 2 quarters · filed 2021-05-03 | -$86.00K derived: sum of 3 quarters · filed 2021-05-03 | -$112.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$59.00K derived: sum of 2 quarters · filed 2021-03-03 | -$85.00K derived: sum of 3 quarters · filed 2021-03-03 | -$110.00K 10-K · filed 2021-03-03 |
| 2019-09-30 | -$26.00K 10-Q · filed 2020-11-04 | -$52.00K derived: sum of 2 quarters · filed 2020-11-04 | -$77.00K 10-Q · filed 2020-11-04 | |
| 2019-06-30 | -$26.00K 10-Q · filed 2020-08-04 | -$51.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | -$24.00K 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |